Bristlecone Health , Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention
Not Applicable
- Conditions
- Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)Diabetic Retinopathy (DR)Mid-peripheral Drusen Formation
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2019-03-04
- Lead Sponsor
- Bristlecone Health, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03859245
- Locations
- 🇺🇸
Yankee Eye Clinic, Eagan, Minnesota, United States
Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation
Not Applicable
Completed
- Conditions
- Mild Cognitive ImpairmentMetabolic Syndrome
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2019-11-12
- Lead Sponsor
- Bristlecone Health, Inc.
- Target Recruit Count
- 98
- Registration Number
- NCT03319173
- Locations
- 🇺🇸
Bristlecone Health, Inc., Maple Grove, Minnesota, United States
News
No news found